Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Alberto Gualtieri
PAX3–FOXO1 Establishes Myogenic Super Enhancers and Confers BET Bromodomain Vulnerability
Cancer Discovery
Oncology
Related publications
Loss of KDM6A Activates Super-Enhancers to Induce Gender-Specific Squamous-Like Pancreatic Cancer and Confers Sensitivity to BET Inhibitors
Cancer Cell
Cancer Research
Oncology
Cell Biology
Acetylation of CCAR2 Establishes a BET/BRD9 Acetyl Switch in Response to Combined Deacetylase and Bromodomain Inhibition
Cancer Research
Cancer Research
Oncology
Bromodomain and Extraterminal (BET) Proteins Regulate Biliary-Driven Liver Regeneration
Journal of Hepatology
Hepatology
BET Bromodomain Proteins Are Therapeutic Targets in CRPC
Cancer Discovery
Oncology
Alveolar Rhabdomyosarcoma–associated PAX3-FOXO1 Promotes Tumorigenesis via Hippo Pathway Suppression
Journal of Clinical Investigation
Medicine
Alveolar Rhabdomyosarcoma – The Molecular Drivers of PAX3/7-FOXO1-induced Tumorigenesis
Skeletal Muscle
Orthopedics
Sports Medicine
Cell Biology
Molecular Biology
Exploring Selective Inhibition of the First Bromodomain of the Human Bromodomain and Extra-Terminal Domain (BET) Proteins
Insulin and LiCl Synergistically Rescue Myogenic Differentiation of FoxO1 Over-Expressed Myoblasts
PLoS ONE
Multidisciplinary
BET Bromodomain Inhibitors Synergize With ATR Inhibitors in Melanoma in Melanoma
Cell Death and Disease
Molecular Neuroscience
Immunology
Cell Biology
Cancer Research
Cellular
Medicine